BGO buys 35,171 sq ft ambulatory surgery center in Durham NC

BGO has completed the acquisition of a fully leased, two‑storey medical building in Durham, North Carolina, marking a strategic expansion of its healthcare property holdings. The asset at 7810 NC Highway 751 spans 35,171 sq. ft. and is 100% occupied by EmergeOrtho, one of the state’s largest orthopaedic provider groups.

The property, developed in 2020, sits at the high‑visibility interchange of Interstate 40 and NC‑751 inside the Research Triangle MSA. That market—anchored by Duke University, the University of North Carolina and North Carolina State University—houses more than 2.2 million residents and the nation’s largest research park, the 7,000‑acre Research Triangle Park, creating durable demand for medical and life‑science real estate.

Kevin Yen, Principal, Investments at BGO, described the purchase as a deliberate bet on outpatient healthcare delivery and demographic resilience. The long‑dated lease with a specialist operator provides predictable cash flow, while the building’s proximity to academic hospitals and research employers enhances tenant stability and patient catchment.

Institutional appetite for medical office and ambulatory surgery centres has risen as care shifts away from inpatient settings. Investors prize these assets for stable net‑lease income and higher specialty tenant retention versus general office product. For BGO—part of a broader alternatives platform with significant global scale—the deal adds a defensive income stream to a diversified portfolio that it manages on behalf of large institutional clients.

Advisors to the deal included brokerage and legal teams working for the respective parties. The seller’s advisor was CBRE, while legal counsel for the buyer included Mintz Levin Cohn Ferris Glovsky & Popeo. Financial terms were not disclosed.

From a market perspective, the acquisition underlines two trends: continued investor interest in single‑tenant medical properties and premium pricing for assets tied to surgical and outpatient services. The Research Triangle’s growing population, concentration of clinical systems and life‑science employers supports rental demand, and investors increasingly view well‑located ambulatory facilities as lower‑volatility components of core‑plus and value‑add strategies.

Looking ahead, the deal positions BGO to capitalise on regional population growth and the secular shift to outpatient care. For regional landlords and healthcare operators, competition for well‑designed ASC space is likely to intensify, pushing owners to prioritise modern clinical infrastructure and proximity to referral networks.